BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 12124823)

  • 1. Influence of p53 mutations on prognosis of patients with glioblastoma.
    Shiraishi S; Tada K; Nakamura H; Makino K; Kochi M; Saya H; Kuratsu J; Ushio Y
    Cancer; 2002 Jul; 95(2):249-57. PubMed ID: 12124823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
    Tada M; Iggo RD; Waridel F; Nozaki M; Matsumoto R; Sawamura Y; Shinohe Y; Ikeda J; Abe H
    Mol Carcinog; 1997 Mar; 18(3):171-6. PubMed ID: 9115587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
    Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood.
    Pollack IF; Hamilton RL; Finkelstein SD; Campbell JW; Martinez AJ; Sherwin RN; Bozik ME; Gollin SM
    Cancer Res; 1997 Jan; 57(2):304-9. PubMed ID: 9000573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 mutation and protein alteration in 50 gliomas. Retrospective study by DNA-sequencing techniques and immunohistochemistry.
    von Eckardstein K; Gries H; Bolik E; Cervós-Navarro J; Tschairkin IN; Patt S
    Histol Histopathol; 1997 Jul; 12(3):611-6. PubMed ID: 9225141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H
    Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
    Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
    Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort.
    Pollack IF; Finkelstein SD; Burnham J; Holmes EJ; Hamilton RL; Yates AJ; Finlay JL; Sposto R;
    Cancer Res; 2001 Oct; 61(20):7404-7. PubMed ID: 11606370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnicity delineates different genetic pathways in malignant glioma.
    Chen P; Aldape K; Wiencke JK; Kelsey KT; Miike R; Davis RL; Liu J; Kesler-Diaz A; Takahashi M; Wrensch M
    Cancer Res; 2001 May; 61(10):3949-54. PubMed ID: 11358811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 mutations in malignant astrocytomas.
    Biernat W; Debiec-Rychter M; Kordek R; Liberski PP
    Pol J Pathol; 1997; 48(4):221-4. PubMed ID: 9529927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors.
    Ren ZP; Olofsson T; Qu M; Hesselager G; Soussi T; Kalimo H; Smits A; Nistér M
    J Neuropathol Exp Neurol; 2007 Oct; 66(10):944-54. PubMed ID: 17917588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
    Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations.
    Tada M; Matsumoto R; Iggo RD; Onimaru R; Shirato H; Sawamura Y; Shinohe Y
    Cancer Res; 1998 May; 58(9):1793-7. PubMed ID: 9581814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer.
    Dong M; Nio Y; Yamasawa K; Toga T; Yue L; Harada T
    J Surg Oncol; 2003 Feb; 82(2):111-20. PubMed ID: 12561067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.
    Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K
    Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and mutation analysis of the p53 gene in astrocytoma.
    Hwang SL; Hong YR; Sy WD; Chai CY; Lin HJ; Howng SL
    J Formos Med Assoc; 1999 Jan; 98(1):31-8. PubMed ID: 10063271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional evaluation of p53 and PTEN gene mutations in gliomas.
    Kato H; Kato S; Kumabe T; Sonoda Y; Yoshimoto T; Kato S; Han SY; Suzuki T; Shibata H; Kanamaru R; Ishioka C
    Clin Cancer Res; 2000 Oct; 6(10):3937-43. PubMed ID: 11051241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations.
    Watanabe T; Nobusawa S; Lu S; Huang J; Mittelbronn M; Ohgaki H
    J Neuropathol Exp Neurol; 2009 Feb; 68(2):210-5. PubMed ID: 19151620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.
    Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B
    Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors for deep situated malignant gliomas treated with linac radiosurgery].
    Wang YY; Bao XF; Li SY; Wu CY
    Ai Zheng; 2002 Oct; 21(10):1149-53. PubMed ID: 12508664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.